Insight

To build a great biopharma deal, don't worry, be happy

To build a great biopharma deal, don't worry, be happy

Big pharma wants you to be happy.  After grilling you with 200 questions about your biotech project, sending an army of experts to trample through your data, dragging your team through a grinding due diligence and then running up and down your supply chain, at the end of the day this outsized partner wants to hear you are pleased with the engagement it is proposing.

Abivax CEO highlights pipeline assets, including lead HIV drug

Abivax CEO highlights pipeline assets, including lead HIV drug


Dec 7, 2017

Abivax CEO Dr. Hartmut Ehrlich talks to Scrip senior editor Lucie Ellis about the progress and next development steps for its lead clinical-stage molecule against...

Digital Health faces formidable hurdles in chronic disease management

Digital Health faces formidable hurdles in chronic disease management


Nov 13, 2017

Bringing healthcare into the digital age would create a greenfield opportunity, opening vast opportunities for devices and drugs.  Yet before companies can start open field...

partnering360®: leverage and cultivate your dealmaker network

partnering360 is the network for dealmakers in the life science industry. This global community of more than 41,000 is constantly growing, and the partnering opportunities continually updating.